Advertisement

Topics

NICE revises its decision on Takeda’s Alunbrig for NSCLC

11:19 EST 19 Feb 2019 | Pharmaceutical Technology

The UK’s pricing regulator the National Institute of Health and Care Excellence (NICE) has revised its previous rejection of Takeda’s...
Read More...

The post NICE revises its decision on Takeda’s Alunbrig for NSCLC appeared first on Pharmaceutical Technology.

Original Article: NICE revises its decision on Takeda’s Alunbrig for NSCLC

NEXT ARTICLE

More From BioPortfolio on "NICE revises its decision on Takeda’s Alunbrig for NSCLC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...